Chiropractors in Milton, VT Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Dr. Francine Therese Tougas, DC, CCSP Chiropractor - Sports Physician Medicare: Not Enrolled in Medicare Practice Location: 165 Route 7 South Unit 101, Milton, VT 05468 Phone: 802-893-1070 Fax: 802-893-0668 |
 Milton Chiropractic Center Chiropractor Medicare: Medicare Enrolled Practice Location: 165 Route 7 S, Unit 101, Milton, VT 05468 Phone: 315-651-3196 |
 Dr. Aubry Tager, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 165 Route 7 S, Milton, VT 05468 Phone: 802-893-1070 Fax: 802-893-0668 |
Milton Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 165 Route 7 S Unit 101, Milton, VT 05468 Phone: 802-893-1070 Fax: 802-893-0668 |
News Archive
New optimised PCR tests for reliable diagnosis of Zika virus
DZIF scientists from the University of Bonn have shown that not all conventional Zika virus molecular diagnostic tests for are sufficiently reliable. They developed optimised assays and a control for quantifying viruses in blood and urine.
Capitol Hill briefing addresses neglected tropical diseases
At a Global Network for Neglected Tropical Diseases (NTD) briefing, held in conjunction with the Congressional Malaria and NTD Caucus in Washington, D.C. on Thursday, "U.S. researchers, pharmaceutical companies and government officials [said] they are making progress in an effort to curb [NTDs], but that they need more money and outside help," VOA News.
TV injury coverage lacking, study finds
Nearly every night, on nearly every TV station in the country, the local newscast features news of the day's car crashes, fires and other injury-causing events.
New therapeutic agent shows potential for treating optic neuritis linked to multiple sclerosis
A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania, with Pittsburgh-based Noveome Biotherapeutics.
Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
› Verified 7 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists
Audiologists